Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 398

1.

[Comparison of primary extraovarian peritoneal serous papillary carcinoma with stage III-IV ovarian papillary serous carcinoma].

Gao YN, Liu JX, Wang W, Li WF, Tang WS.

Zhonghua Zhong Liu Za Zhi. 2005 Mar;27(3):171-3. Chinese.

PMID:
15946570
2.

Peritoneal papillary serous carcinoma: study of 15 cases and comparison with stage III-IV ovarian papillary serous carcinoma.

Piura B, Meirovitz M, Bartfeld M, Yanai-Inbar I, Cohen Y.

J Surg Oncol. 1998 Jul;68(3):173-8.

PMID:
9701210
3.

Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study.

Bloss JD, Brady MF, Liao SY, Rocereto T, Partridge EE, Clarke-Pearson DL; Gynecologic Oncology Group Study.

Gynecol Oncol. 2003 Apr;89(1):148-54.

PMID:
12694669
4.

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary.

Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, McMeekin S, Bloss LP, DiSaia PJ.

Gynecol Oncol. 1993 Sep;50(3):347-51.

PMID:
8406199
5.

Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?

Ayhan A, Taskiran C, Yigit-Celik N, Bozdag G, Gultekin M, Usubutun A, Guler N, Yuce K.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):484-9.

PMID:
16681715
6.

Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.

Dubernard G, Morice P, Rey A, Camatte S, Fourchotte V, Thoury A, Pomel C, Pautier P, Lhommé C, Duvillard P, Castaigne D.

Eur J Surg Oncol. 2004 Nov;30(9):976-81.

PMID:
15498644
7.

[Comparison of clinical characteristics of extraovarian peritoneal serous papillary carcinoma with papillary serous ovarian carcinoma].

Peng YZ, Shen K, Wu M, Huang HF, Pan LY, Yang JX, Lang JH.

Zhonghua Fu Chan Ke Za Zhi. 2005 Apr;40(4):243-5. Chinese.

PMID:
15924670
8.

Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma.

Ben-Baruch G, Sivan E, Moran O, Rizel S, Menczer J, Seidman DS.

Gynecol Oncol. 1996 Mar;60(3):393-6.

PMID:
8774644
9.

[Impact of neoadjuvant chemotherapy on the survival of patients with stage IIIc and IV epithelial ovarian cancer].

Yan X, An N, Jiang GQ, Gao M, Gao YN.

Zhonghua Zhong Liu Za Zhi. 2008 Apr;30(4):298-301. Chinese.

PMID:
18788637
10.

[Extraovarian peritoneal serous papillary carcinoma: an unusual surgical case].

Meier C, Seifert M, Wehrli H.

Swiss Surg. 1999;5(1):14-7. German.

PMID:
10073126
11.

Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.

Sood BM, Jones J, Gupta S, Khabele D, Guha C, Runowicz C, Goldberg G, Fields A, Anderson P, Vikram B.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):208-16.

PMID:
12909235
12.

Uterine papillary serous carcinoma. A clinical study.

Gitsch G, Friedlander ML, Wain GV, Hacker NF.

Cancer. 1995 May 1;75(9):2239-43.

13.

Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).

Goldberg H, Miller RC, Abdah-Bortnyak R, Steiner M, Yildiz F, Meirovitz A, Villà S, Poortmans PM, Azria D, Zidan J, Ozsahin M, Abacioglu U, Gold DG, Amit A, Lavie O, Atahan IL, Kuten A; Rare Cancer Network.

Gynecol Oncol. 2008 Feb;108(2):298-305. Epub 2007 Dec 21.

PMID:
18096209
14.

Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

Pectasides D, Fountzilas G, Aravantinos G, Kalofonos C, Efstathiou H, Farmakis D, Skarlos D, Pavlidis N, Economopoulos T, Dimopoulos MA.

Gynecol Oncol. 2006 Aug;102(2):285-91. Epub 2006 Mar 3.

PMID:
16516283
15.

Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary.

Gershenson DM, Sun CC, Lu KH, Coleman RL, Sood AK, Malpica A, Deavers MT, Silva EG, Bodurka DC.

Obstet Gynecol. 2006 Aug;108(2):361-8.

PMID:
16880307
16.

[Extraovarian peritoneal serous papillary carcinoma: studies of clinical and pathological features].

Shi X, Guo Y, Li J.

Zhonghua Fu Chan Ke Za Zhi. 1996 Dec;31(12):711-3. Chinese.

PMID:
9387509
18.

Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).

Levenback C, Burke TW, Silva E, Morris M, Gershenson DM, Kavanagh JJ, Wharton JT.

Gynecol Oncol. 1992 Sep;46(3):317-21.

PMID:
1526508
19.

Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.

Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, Aydin Y, Topuz E.

Gynecol Oncol. 2008 Jan;108(1):136-40. Epub 2007 Oct 23.

PMID:
17936342
20.

Borderline ovarian tumours: retrospective analysis of twenty-one cases.

Saygili U, Uslu T, Erten O, Doğan E.

Eur J Gynaecol Oncol. 1998;19(2):182-5.

PMID:
9611063

Supplemental Content

Support Center